InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

CXM Insider Trading

Insider Ownership Percentage: 39.58%
Insider Buying (Last 12 Months): A$102,791.60
Insider Selling (Last 12 Months): A$0.00

Centrex Insider Trading History Chart

This chart shows the insider buying and selling history at Centrex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Centrex Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for CXM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Centrex Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/20/2024Peter HuntInsiderBuy175,439A$0.06A$9,649.15
12/5/2023Graham ChrispInsiderBuy94,500A$0.07A$6,142.50
9/28/2023Robert MencelInsiderBuy55,555A$0.09A$4,999.95
9/12/2023Robert MencelInsiderBuy1,000,000A$0.08A$82,000.00
12/21/2022Peter HuntInsiderIssued1,500,000A$0.13A$195,000.00
6/20/2022Robert MencelInsiderBuy1,000,000A$0.11A$110,000.00
6/2/2021Graham ChrispInsiderIssued1A$1,000,000.00A$1,000,000.00
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Centrex (ASX:CXM)

0.03% of Centrex stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Centrex logo
Centrex Limited, together with its subsidiaries, engages in the exploration, evaluation, development, and production of mineral resources in Australia. The company produces phosphate rock, as well as explores for potash, zinc, and copper. Its flagship project is the Ardmore phosphate rock project located to the south of Mount Isa in North West Queensland. It holds 100% interests in the Oxley Potash Project in the Midwest of Western Australia; and the Goulburn base metals project located in the Lachlan Fold Belt, New South Wales. The company was formerly known as Centrex Metals Limited and changed its name to Centrex Limited in December 2021. Centrex Limited was founded in 2001 and is based in Adelaide, Australia.
Read More on Centrex

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

5.84%

Beta

1.24

Who are the company insiders with the largest holdings of Centrex?

Centrex's top insider shareholders include:
  1. Graham Chrisp (Insider)
  2. Peter Hunt (Insider)
  3. Robert Mencel (Insider)
Learn More about top insider investors at Centrex.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...